Dimensional Fund Advisors LP Reduces Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Dimensional Fund Advisors LP lessened its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,907,066 shares of the company's stock after selling 51,952 shares during the period. Dimensional Fund Advisors LP owned approximately 5.88% of Prestige Consumer Healthcare worth $227,011,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in Prestige Consumer Healthcare by 3.2% during the third quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company's stock valued at $19,630,000 after purchasing an additional 8,533 shares in the last quarter. Avior Wealth Management LLC boosted its position in Prestige Consumer Healthcare by 1,570.7% during the fourth quarter. Avior Wealth Management LLC now owns 8,554 shares of the company's stock worth $668,000 after purchasing an additional 8,042 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Prestige Consumer Healthcare by 5.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock valued at $49,667,000 after purchasing an additional 33,844 shares during the period. Norges Bank acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth approximately $40,009,000. Finally, Barclays PLC grew its stake in Prestige Consumer Healthcare by 346.3% during the 3rd quarter. Barclays PLC now owns 92,444 shares of the company's stock valued at $6,665,000 after acquiring an additional 71,730 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on PBH shares. Royal Bank of Canada lifted their price objective on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a research note on Friday, March 21st. DA Davidson boosted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Canaccord Genuity Group raised their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a report on Friday, February 7th. StockNews.com cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th. Finally, Oppenheimer lifted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Prestige Consumer Healthcare has an average rating of "Hold" and a consensus target price of $93.33.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now owns 17,157 shares in the company, valued at $1,544,130. This trade represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Stock Performance

Shares of PBH traded up $0.99 during mid-day trading on Friday, hitting $80.52. 270,919 shares of the company's stock were exchanged, compared to its average volume of 286,839. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $90.04. The business's 50 day moving average is $83.69 and its two-hundred day moving average is $80.39. The firm has a market capitalization of $3.99 billion, a P/E ratio of 18.86, a P/E/G ratio of 2.69 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.